Pfizer Limited (NSE:PFIZER)
5,882.50
-6.50 (-0.11%)
Jun 13, 2025, 3:29 PM IST
Pfizer Revenue
In the fiscal year ending March 31, 2025, Pfizer had annual revenue of 22.81B INR with 4.02% growth. Pfizer had revenue of 5.92B in the quarter ending March 31, 2025, with 8.28% growth.
Revenue
22.81B
Revenue Growth
+4.02%
P/S Ratio
11.80
Revenue / Employee
13.26M
Employees
1,721
Market Cap
269.11B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 22.81B | 881.80M | 4.02% |
Mar 31, 2024 | 21.93B | -2.32B | -9.55% |
Mar 31, 2023 | 24.25B | -1.86B | -7.13% |
Mar 31, 2022 | 26.11B | 3.71B | 16.54% |
Mar 31, 2021 | 22.40B | 887.20M | 4.12% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 525.78B |
Divi's Laboratories | 93.60B |
Cipla | 271.45B |
Apollo Hospitals Enterprise | 217.94B |
Mankind Pharma | 122.07B |
Zydus Lifesciences | 232.42B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |